Nitromint (Glyceryl Trinitrate)

Glyceryl trinitrate, the active ingredient in Nitromint, is a nitrate vasodilator presented as an oral formulation for oral use. It treats angina pectoris and related cardiac conditions in adults.

GNH USA supplies Nitromint as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitromint (glyceryl trinitrate) is used in the management of coronary artery disease and related conditions.

- Angina pectoris: relieves chest pain by improving myocardial oxygen supply. - Acute coronary syndrome: reduces cardiac workload during acute events. - Heart failure: alleviates symptoms by decreasing preload and afterload.

Nitromint may cause several adverse reactions, ranging from mild to serious.

Common Side Effects: - Headache: throbbing pain often triggered by vasodilation. - Dizziness: sensation of light‑headedness due to lowered blood pressure. - Flushing: warmth and redness of the skin, especially on the face. - Hypotension: measurable drop in systolic or diastolic pressure. - Nausea: upset stomach, sometimes accompanied by vomiting. - Tachycardia: compensatory increase in heart rate.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall leading to fainting. - Syncope: sudden loss of consciousness. - Myocardial infarction: rare occurrence of heart attack. - Methemoglobinemia: abnormal hemoglobin causing reduced oxygen delivery. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Tolerance development: diminished response requiring dose escalation.

Before prescribing Nitromint, clinicians should consider several safety measures.

- Monitor blood pressure: check for excessive drops after dosing. - Avoid concurrent nitrates: combined use can cause profound hypotension. - Caution with phosphodiesterase‑5 inhibitors: contraindicated within 24–48 hours. - Assess anemia or hypovolemia: patients with low hemoglobin may be more susceptible to hypotension. - Do not discontinue abruptly: tapering may be needed to avoid rebound angina. - Store at ambient temperature: keep below 25 °C in the original pack, protect from moisture.

Nitromint can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): risk of severe hypotension. - Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect. - Guanylate cyclase stimulators: may amplify blood pressure reduction.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., ACE inhibitors, ARBs): may enhance blood pressure lowering. - Diuretics: can increase risk of volume depletion and hypotension. - Beta‑blockers: may mask tachycardia signs of hypotension. - Certain antiretrovirals (e.g., ritonavir): may affect nitrate metabolism. - Azole antifungals (e.g., ketoconazole): potential pharmacokinetic interaction.